{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:29:41Z","timestamp":1787239781676,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10549-021-06499-8","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T16:08:43Z","timestamp":1653062923000},"page":"257-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Accuracy of the Breast Cancer Surveillance Consortium Model Among Women with LCIS"],"prefix":"10.1007","volume":"194","author":[{"given":"Idil","family":"Eroglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varadan","family":"Sevilimedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0508-6424","authenticated-orcid":false,"given":"Melissa L.","family":"Pilewskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"issue":"24","key":"6499_CR1","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","volume":"23","author":"PJ Chuba","year":"2005","unstructured":"Chuba PJ, Hamre MR, Yap J et al (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23(24):5534\u20135541","journal-title":"J Clin Oncol"},{"issue":"10","key":"6499_CR2","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1245\/s10434-013-3121-4","volume":"20","author":"PR Portschy","year":"2013","unstructured":"Portschy PR, Marmor S, Nzara R, Virnig BA, Tuttle TM (2013) Trends in incidence and management of lobular carcinoma in situ: a population-based analysis. Ann Surg Oncol 20(10):3240\u20133246","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"6499_CR3","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","volume":"33","author":"TA King","year":"2015","unstructured":"King TA, Pilewskie M, Muhsen S et al (2015) Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol 33(33):3945\u20133952","journal-title":"J Clin Oncol"},{"issue":"9","key":"6499_CR4","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1245\/s10434-017-5867-6","volume":"24","author":"SM Wong","year":"2017","unstructured":"Wong SM, King T, Boileau JF, Barry WT, Golshan M (2017) Population-based analysis of breast cancer incidence and survival outcomes in women diagnosed with lobular carcinoma in situ. Ann Surg Oncol 24(9):2509\u20132517","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"6499_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7326\/0003-4819-148-5-200803040-00004","volume":"148","author":"JA Tice","year":"2008","unstructured":"Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K (2008) Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 148(5):337\u2013347","journal-title":"Ann Intern Med"},{"issue":"28","key":"6499_CR6","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/JCO.2015.60.8869","volume":"33","author":"JA Tice","year":"2015","unstructured":"Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K (2015) Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol 33(28):3137\u20133143","journal-title":"J Clin Oncol"},{"issue":"7","key":"6499_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111\u20131130","journal-title":"Stat Med"},{"issue":"3","key":"6499_CR8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1245\/s10434-019-07814-w","volume":"27","author":"MG Valero","year":"2020","unstructured":"Valero MG, Zabor EC, Park A et al (2020) The Tyrer-Cuzick Model inaccurately predicts invasive breast cancer risk in women with LCIS. Ann Surg Oncol 27(3):736\u2013740","journal-title":"Ann Surg Oncol"},{"issue":"22","key":"6499_CR9","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1200\/JCO.2010.28.0784","volume":"28","author":"JC Boughey","year":"2010","unstructured":"Boughey JC, Hartmann LC, Anderson SS et al (2010) Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol 28(22):3591\u20133596","journal-title":"J Clin Oncol"},{"issue":"16","key":"6499_CR10","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1002\/cncr.31528","volume":"124","author":"RD Frank","year":"2018","unstructured":"Frank RD, Winham SJ, Vierkant RA et al (2018) Evaluation of 2 breast cancer risk models in a benign breast disease cohort. Cancer 124(16):3319\u20133328","journal-title":"Cancer"},{"key":"6499_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju397","author":"CM Vachon","year":"2015","unstructured":"Vachon CM, Pankratz VS, Scott CG et al (2015) The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju397","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"3","key":"6499_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1245\/s10434-019-07875-x","volume":"27","author":"DM Euhus","year":"2020","unstructured":"Euhus DM (2020) Why breast cancer risk models fail: the case of lobular carcinoma in situ. Ann Surg Oncol 27(3):627\u2013629","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6499_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41416-018-0120-z","volume":"119","author":"LL Lo","year":"2018","unstructured":"Lo LL, Milne RL, Liao Y, Cuzick J, Terry MB, Phillips KA (2018) Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ. Br J Cancer 119(1):36\u201339","journal-title":"Br J Cancer"},{"issue":"7","key":"6499_CR14","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","volume":"115","author":"NR Cook","year":"2007","unstructured":"Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928\u2013935","journal-title":"Circulation"},{"issue":"2","key":"6499_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10549-013-2725-5","volume":"142","author":"TA King","year":"2013","unstructured":"King TA, Muhsen S, Patil S et al (2013) Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat 142(2):445\u2013453","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"6499_CR16","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1245\/s10434-006-9195-5","volume":"14","author":"ER Port","year":"2007","unstructured":"Port ER, Park A, Borgen PI, Morris E, Montgomery LL (2007) Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 14(3):1051\u20131057","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"6499_CR17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-012-2318-8","volume":"136","author":"SB Coopey","year":"2012","unstructured":"Coopey SB, Mazzola E, Buckley JM et al (2012) The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat 136(3):627\u2013633","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"6499_CR18","first-page":"698","volume":"159","author":"VA Moyer","year":"2013","unstructured":"Moyer VA (2013) Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 159(10):698\u2013708","journal-title":"Ann Intern Med"},{"issue":"2","key":"6499_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75\u201389","journal-title":"CA Cancer J Clin"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06499-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06499-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06499-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T14:34:18Z","timestamp":1656426858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06499-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["6499"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06499-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"4 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"MSKCC IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"NA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"NA.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}